Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Giornale Italiano Di Cardiologia|January 1, 1993
[Congenital isolated complete atrioventricular block: long-term experience with 38 patients]M Cecconi, R Renzi, M G Bettuzzi, et al.British Journal of Sports Medicine|July 27, 2016
Impact of the national prevention policy and scrum law changes on the incidence of rugby-related catastrophic cervical spine injuries in French Rugby UnionE Reboursiere, Y Bohu, D Retière, et al.BMC Cardiovascular Disorders|December 1, 2020
Elderly patients with atrial fibrillation in routine clinical practice-peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF studyM Unverdorben, C von Heymann, A Santamaria, et al.Journal of Molecular Recognition : JMR|November 1, 1989
Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificityV Rizzo, C Battistini, A Vigevani, et al.Giornale Italiano Di Cardiologia|February 1, 1991
[Competitive sports activity in subjects undergoing the surgical correction of an ostium-secundum type of interatrial defect: the experience of 9 cases]M Cecconi, P Colonna, M G Bettuzzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.European Journal of Haematology|October 1, 1987
Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.Nucleic Acids Research|September 11, 1993
L-DNAs as potential antimessenger oligonucleotides: a reassessmentA Garbesi, M L Capobianco, F P Colonna, et al.American Journal of Hematology|March 1, 1989
Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiationP Colonna, J M Andrieu, R Ghouadni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stagesJ M Andrieu, J P Jais, P Colonna, et al.Pageof 14